Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
US Department of Justice
Covington
AstraZeneca
Moodys
Medtronic
McKinsey
Deloitte
Citi

Generated: June 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020929

« Back to Dashboard

NDA 020929 describes PULMICORT RESPULES, which is a drug marketed by Astrazeneca Pharms and is included in one NDA. It is available from three suppliers. There are three patents protecting this drug and two Paragraph IV challenges. Additional details are available on the PULMICORT RESPULES profile page.

The generic ingredient in PULMICORT RESPULES is budesonide. There are twenty-one drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the budesonide profile page.
Pharmacology for NDA: 020929
Medical Subject Heading (MeSH) Categories for 020929
Suppliers and Packaging for NDA: 020929
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PULMICORT RESPULES budesonide SUSPENSION;INHALATION 020929 NDA AstraZeneca Pharmaceuticals LP 0186-1988 N 0186-1988-04
PULMICORT RESPULES budesonide SUSPENSION;INHALATION 020929 NDA AstraZeneca Pharmaceuticals LP 0186-1989 N 0186-1989-04

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SUSPENSION;INHALATIONStrength0.25MG/2ML
Approval Date:Aug 8, 2000TE:ANRLD:Yes
Patent:➤ Sign UpPatent Expiration:Jun 23, 2019Product Flag?Substance Flag?Delist Request?Y
Patent:➤ Sign UpPatent Expiration:Jun 23, 2019Product Flag?Substance Flag?Delist Request?Y
Patent:➤ Sign UpPatent Expiration:May 11, 2019Product Flag?Substance Flag?Delist Request?Y

Expired US Patents for NDA 020929

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca Pharms PULMICORT RESPULES budesonide SUSPENSION;INHALATION 020929-002 Aug 8, 2000 ➤ Sign Up ➤ Sign Up
Astrazeneca Pharms PULMICORT RESPULES budesonide SUSPENSION;INHALATION 020929-003 Aug 8, 2000 ➤ Sign Up ➤ Sign Up
Astrazeneca Pharms PULMICORT RESPULES budesonide SUSPENSION;INHALATION 020929-001 Aug 8, 2000 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
McKinsey
Fuji
Accenture
Baxter
Citi
Cantor Fitzgerald
Dow
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.